Compare AdaptHealth Corp (AHCO) vs Intuit Inc. (INTU) Price & Performance

AdaptHealth (AHCO) trades at $10.27, down 4.55% today, with neutral technical signals and mixed fundamental performance. The company reported Q1 2026 earnings miss with negative EPS of -$0.06 versus $0.0125 expected, continuing a pattern of recent quarterly misses. Despite revenue growth to $3.3B projected for 2026, net income remains negative with -2.43% margin. Analyst consensus remains bullish with 75% buy ratings and $14.80 price target, representing 44% upside potential from current levels.

The investment case balances strong analyst support and reasonable valuation (P/S 0.42, EV/EBITDA 7.17) against persistent profitability challenges. Recent refinancing improves financial flexibility, but execution on cost controls and margin improvement remains critical. The stock offers significant upside if management can translate revenue growth into sustainable profitability, though current negative earnings trend presents near-term headwinds.

Intuit (INTU) trades at $272.10, down slightly by 0.01% on the day. The stock shows strong fundamentals with consistent earnings beats, including Q1 2026 EPS of $12.80 versus $12.57 expected. Revenue grew to $18.83 billion in 2025, with a net income margin of 21.91%. Technical indicators are mixed, with a bullish overall signal but bearish moving averages. Recent news highlights legal investigations following a 20% stock drop, though analyst consensus remains largely positive with a $433.69 price target.

Outlook is cautiously optimistic given robust profitability and AI-driven growth potential, but near-term risks include ongoing securities fraud probes and competitive pressures. The stock presents a value opportunity if legal concerns subside, supported by high institutional buy ratings and solid cash flow generation.